Influenza vaccine‐associated cutaneous lupus erythematosus-Reference-Cited by-同舟云学术

Influenza vaccine‐associated cutaneous lupus erythematosus

Published:2019-11-17 Issue:4 Volume:45 Page:450-452
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Mintoff D.¹^ORCID,Betts A.²,Boffa M. J.¹

Affiliation:

1. Department of Dermatology Sir Paul Boffa Hospital Floriana Malta

2. Department of Pathology Mater Dei Hospital Msida Malta

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14130

Reference11 articles.

1. Cutaneous Lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index Instrument

2. Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus

3. Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis

4. Vaccination in SLE patients

5. WorldHealthOrganization.Recommended composition of influenza virus vaccines for use in the 2018–19 northern hemisphere influenza season.Available at:http://www.who.int/influenza/vaccines/virus/recommendations/2018_19_north/en/(accessed 18 October 2019).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Adverse Reactions Following Influenza Vaccination in Adults;Advances in Skin & Wound Care;2023-06

2. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective;Vaccines;2021-08-25

3. Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine;Dermatologic Therapy;2021-06-08

4. Influenza virus vaccine/mycophenolic-acid/prednisolone;Reactions Weekly;2020-06